Automated Nucleic Acid Extraction Market Set to Grow from USD 3.6 Billion in 2025 to USD 11.7 Billion by 2036, Driven by Rising Demand for Precision Diagnostics – TMR Analysis

The global automated nucleic acid extraction market is expected to experience robust growth over the forecast period as laboratories and healthcare institutions increasingly adopt automated workflows to improve efficiency, accuracy, and reproducibility. According to the latest market analysis, the Global Automated Nucleic Acid Extraction Market was valued at US$ 3.6 Billion in 2025 and is projected to reach US$ 11.7 Billion by 2036, expanding at a CAGR of 11.4% from 2026 to 2036.

Automated nucleic acid extraction systems are widely used for isolating DNA and RNA from biological samples for applications including molecular diagnostics, next-generation sequencing (NGS), PCR testing, infectious disease detection, oncology research, forensic science, and personalized medicine. Increasing use of automated extraction assays in cancer diagnostics, minimal residual disease monitoring, companion diagnostics, and epigenetics research continues to accelerate market growth.

👉 Request a Sample PDF of this Strategic Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86934

Leading Companies Operating in the Market

The global automated nucleic acid extraction market remains highly competitive, with leading companies focusing on automation technologies, high-throughput extraction platforms, reagent innovation, and strategic collaborations to strengthen their global market presence.

Major companies operating in the market include:

• Thermo Fisher Scientific Inc.
• QIAGEN
• Revvity
• MP Biomedicals
• F. Hoffmann-La Roche Ltd.
• Agilent Technologies, Inc.
• Promega Corporation
• Bio-Rad Laboratories, Inc.
• Takara Bio Inc.
• Analytik Jena GmbH+Co. KG
• 3CR Bioscience
• HiMedia Laboratories
• Biogenuix
• GeneAll Biotechnology Co., Ltd.

These companies continue to invest in automated laboratory solutions, reagent development, molecular diagnostic technologies, and global expansion initiatives to strengthen their competitive positions.

Rising Demand for Molecular Diagnostics Driving Market Growth

The growing prevalence of infectious diseases, cancer, and genetic disorders is significantly increasing the demand for rapid and reliable nucleic acid extraction technologies.

Clinical laboratories, hospitals, biotechnology companies, and research institutions are increasingly adopting automated extraction platforms to improve laboratory efficiency, minimize manual errors, and support high-throughput testing. The expansion of precision medicine and genomic testing is expected to further accelerate market demand.

Expanding Applications in Oncology and Precision Medicine Supporting Industry Growth

Automated nucleic acid extraction technologies are playing an increasingly important role in cancer diagnostics and personalized healthcare.

Key Growth Drivers Include:

• Rising adoption of molecular diagnostics
• Growing applications in oncology and companion diagnostics
• Increasing demand for early cancer detection
• Expansion of epigenetics and genomic research
• Growing use of next-generation sequencing (NGS)
• Rising laboratory automation across healthcare facilities

These trends are encouraging healthcare providers and research organizations to invest in advanced automated extraction technologies.

Technology Innovation Reshaping the Industry

Manufacturers are continuously introducing innovative automation platforms that improve extraction speed, sample quality, and laboratory productivity.

Key Innovation Trends Include:

• Fully automated nucleic acid extraction systems
• High-throughput laboratory automation
• AI-enabled workflow optimization
• Advanced magnetic bead extraction technologies
• Integrated sample-to-result diagnostic platforms
• Improved reagent and consumable solutions
• Compact extraction systems for decentralized laboratories

These innovations are enabling laboratories to deliver faster, more accurate, and highly reproducible molecular testing results.

👉 Request your Sample Research Report today and make your next strategic decision with confidence. https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86934

Key Market Highlights

• The global automated nucleic acid extraction market reached US$ 3.6 Billion in 2025
• The market is expected to reach US$ 11.7 Billion by 2036
• The industry is projected to expand at a CAGR of 11.4% from 2026 to 2036
• North America dominated the market in 2025 with a 41.6% revenue share
• The Reagents and Consumables segment accounted for the largest market share of 69.4% in 2025
• Increasing adoption of automated molecular testing continues to support long-term market growth.

Why Investors Are Watching This Market

The automated nucleic acid extraction market presents significant investment opportunities due to the rapid expansion of molecular diagnostics, precision medicine, and genomic research.

Key Investment Drivers:

• Strong long-term market growth through 2036
• Increasing global adoption of laboratory automation
• Rising investments in precision medicine
• Growing demand for oncology and infectious disease diagnostics
• Continuous innovation in genomic technologies
• Expanding research funding for molecular biology

As healthcare systems increasingly prioritize automation and precision diagnostics, demand for automated nucleic acid extraction solutions is expected to rise substantially.

Significant Opportunities for Manufacturers

Manufacturers are well-positioned to capitalize on increasing laboratory automation and expanding molecular testing applications.

Strategic Growth Opportunities:

• Development of next-generation automated extraction platforms
• Expansion of reagent and consumable portfolios
• Integration with NGS and molecular diagnostic workflows
• Geographic expansion into emerging healthcare markets
• Strategic collaborations with diagnostic laboratories
• Investment in AI-enabled laboratory automation technologies

Companies focusing on innovation, workflow efficiency, and precision diagnostics are expected to strengthen their market leadership during the forecast period.

Expanding Revenue Potential Across Healthcare and Research Sectors

Growing utilization of automated nucleic acid extraction technologies is creating substantial opportunities for diagnostic laboratories, hospitals, biotechnology companies, pharmaceutical firms, and academic research institutions.

Key Benefits Across the Value Chain:

• Higher demand for molecular diagnostic testing
• Expansion of precision medicine programs
• Increased adoption of genomic research technologies
• Growing demand for laboratory automation
• Rising use in pharmaceutical research and clinical trials
• Opportunities for strategic collaborations and technology partnerships

The convergence of automation, molecular biology, and precision healthcare is expected to drive sustained market growth worldwide.

Purchase the Report to Support Strategic Business Decisions

Organizations across the healthcare and life sciences value chain can leverage the report to:

• Identify high-growth market segments
• Develop expansion and investment strategies
• Benchmark competitors and industry leaders
• Evaluate partnership and acquisition opportunities
• Optimize product development and commercialization plans
• Support long-term strategic business planning initiatives

Purchase the complete Automated Nucleic Acid Extraction Market Report today and gain actionable intelligence to stay ahead in the rapidly evolving molecular diagnostics industry.

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=86934<ype=S

Actionable Insights for Business Decision-Makers

Business leaders across the molecular diagnostics ecosystem are increasingly focusing on automation, precision medicine, and advanced genomic technologies to strengthen their competitive positions.

Critical Areas of Focus:

✔ Laboratory automation and workflow optimization

✔ Molecular diagnostics innovation

✔ Precision medicine and companion diagnostics

✔ Genomic and epigenetics research

✔ Strategic partnerships and acquisitions

✔ Regional market expansion initiatives

Organizations that proactively invest in automated extraction technologies, advanced molecular diagnostics, and integrated laboratory solutions will be well-positioned to capture future growth opportunities within the global automated nucleic acid extraction market.

Explore Latest Research Reports by Transparency Market Research

➤ Microplate Reader Market

➤ Next Generation Sequencers (NGS) Market

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Media Contact: 

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com 

Media Inquiries: media@transparencymarketresearch.com

Sales Inquiries: sales@transparencymarketresearch.com